Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

SELL
$2.6 - $4.23 $184 - $300
-71 Reduced 14.79%
409 $1,000
Q2 2023

Jul 17, 2023

SELL
$3.2 - $4.33 $812 - $1,099
-254 Reduced 34.6%
480 $2,000
Q1 2023

May 02, 2023

BUY
$3.79 - $6.22 $1,174 - $1,928
310 Added 73.11%
734 $3,000
Q4 2022

Jan 26, 2023

SELL
$3.53 - $5.49 $84 - $131
-24 Reduced 5.36%
424 $2,000
Q3 2022

Oct 31, 2022

SELL
$3.74 - $7.09 $37 - $70
-10 Reduced 2.18%
448 $2,000
Q2 2022

Jul 19, 2022

SELL
$4.33 - $7.45 $77 - $134
-18 Reduced 3.78%
458 $3,000
Q1 2022

May 03, 2022

BUY
$5.84 - $13.61 $473 - $1,102
81 Added 20.51%
476 $3,000
Q4 2021

Feb 07, 2022

SELL
$12.52 - $19.02 $2,504 - $3,804
-200 Reduced 33.61%
395 $5,000
Q3 2021

Oct 25, 2021

BUY
$10.47 - $20.87 $607 - $1,210
58 Added 10.8%
595 $8,000
Q2 2021

Jul 26, 2021

BUY
$13.9 - $22.58 $7,464 - $12,125
537 New
537 $11,000

Others Institutions Holding DRIO

About DarioHealth Corp.


  • Ticker DRIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 23,295,000
  • Market Cap $17.2M
  • Description
  • DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...
More about DRIO
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.